We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$54.7M
AUM Growth
-$48.9M
Cap. Flow
-$18.7M
Cap. Flow %
-34.12%
Top 10 Hldgs %
82.31%
Holding
42
New
10
Increased
6
Reduced
2
Closed
16

Top Buys

Rank Stock Value
1
AMRI
Albany Molecular Research Inc
AMRI
+$1.84M
2
AZN icon
AstraZeneca
AZN
+$1.79M
3
PFE icon
Pfizer
PFE
+$1.51M
4
QLTI
QLT Inc
QLTI
+$1.37M
5
AORT icon
Artivion
AORT
+$1.29M

Top Sells

Rank Stock Value
1
ANIP icon
ANI Pharmaceuticals
ANIP
+$9.9M
2
AGN
Allergan plc
AGN
+$7.24M
3
TWM icon
ProShares UltraShort Russell2000
TWM
+$5.56M
4
BIS icon
ProShares UltraShort NASDAQ Biotechnology
BIS
+$2.41M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 82.99%
2 Miscellaneous 17.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRX
26
DELISTED
Catalyst Pharmaceutical
CPRX
$149K 0.27%
+50,000
New +$137K
ANIP icon
27
ANI Pharmaceuticals
ANIP
$1.69B
– –
-350,000
Closed -$9.9M
AZN icon
28
CALL
AstraZeneca
AZN
$255B
– –
-50,000
Closed -$3.57M
BIS icon
29
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.77M
– –
-5,000
Closed -$2.41M
BMY icon
30
PUT
Bristol-Myers Squibb
BMY
$137B
– –
-50,000
Closed -$2.56M
MRK icon
31
CALL
Merck
MRK
$369B
– –
-104,800
Closed -$5.93M
PFE icon
32
CALL
Pfizer
PFE
$160B
– –
-210,800
Closed -$5.91M
VIRX
33
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-476
Closed -$714K
CLVS
34
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-25,000
Closed -$1.13M
KIN
35
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-50,000
Closed -$463K
AGN
36
CALL
DELISTED
Allergan plc
AGN
– –
-25,000
Closed -$6.03M
AGN
37
DELISTED
Allergan plc
AGN
– –
-30,000
Closed -$7.24M
SCMP
38
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
– –
-51,630
Closed -$336K
CEMP
39
DELISTED
Cempra, Inc.
CEMP
– –
-50,000
Closed -$747K
ZGNX
40
DELISTED
Zogenix, Inc.
ZGNX
– –
-18,750
Closed -$173K
AUXL
41
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-200,000
Closed -$5.97M
VXX
42
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-6,250
Closed -$3.12M
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Healthcare Value Capital held 42 positions worth $54.7M, down 47% from $104M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Healthcare Value Capital withdrew a net $18.7M in Q4 2014, closing 16 positions and reducing 2 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $9.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, up from 54% a quarter earlier, followed by Miscellaneous.

Against the trend, Healthcare Value Capital opened a new position in QLT Inc worth $1.4M.

  • Healthcare Value Capital's largest Q4 2014 buy was QLT Inc: 350,000 shares worth $1.4M.
  • Healthcare Value Capital added most to Albany Molecular Research Inc in Q4 2014, an estimated $1.84M increase.
  • Healthcare Value Capital's biggest Q4 2014 reduction was ProShares UltraShort Russell2000, cutting an estimated $5.56M.
  • Healthcare Value Capital fully exited ANI Pharmaceuticals in Q4 2014, selling an estimated $9.9M.
  • Healthcare Value Capital's ten largest holdings make up 82% of its $54.7M portfolio in Q4 2014.
  • Healthcare Value Capital opened 10 new positions and closed 16 in Q4 2014.
  • Healthcare Value Capital's portfolio value fell 47% quarter-over-quarter to $54.7M.

Based on Healthcare Value Capital's 13F filing for Q4 2014, filed 13 Feb 2015.